|
Real-time Estimate
Cboe BZX
01:17:47 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 21.81 USD | +1.54% |
|
-0.32% | -68.57% |
| 09-30 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09-21 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 1.53B 1.37B 1.27B 1.15B 2.15B 146B 2.18B 15.19B 6.05B 76.34B 5.75B 5.63B 242B | P/E 2026 * |
-13.3x | P/E 2027 * | -9.83x |
|---|---|---|---|---|---|
| Enterprise Value | 565M 507M 468M 424M 792M 53.77B 802M 5.6B 2.23B 28.14B 2.12B 2.07B 89.33B | EV / Sales 2026 * |
13.5x | EV / Sales 2027 * | 21,398x |
| Free-Float |
94.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GPCR | Delayed | |
CBOE
| GPCR | Real-time |
Last Transcript: Structure Therapeutics Inc.
| 1 day | +1.56% | ||
| 1 week | -0.32% | ||
| Current month | -30.09% | ||
| 1 month | -33.13% | ||
| 3 months | -53.83% | ||
| 6 months | -47.15% | ||
| Current year | -68.57% |
| 1 week | 20.5 |  | 22.16 |
| 1 month | 20.5 | | 33.05 |
| Current year | 20.5 | | 94.77 |
| 1 year | 20.5 | | 94.9 |
| 3 years | 13.22 | | 94.9 |
| 5 years | 13.22 | | 94.9 |
| 10 years | 13.22 | | 94.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Yoon
DFI | Director of Finance/CFO | 48 | 01/05/2022 |
Raymond Stevens
CEO | Chief Executive Officer | 62 | 01/05/2019 |
Matthew Lang
COO | Chief Operating Officer | 49 | 15/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Stevens
BRD | Director/Board Member | 62 | 01/02/2019 |
Daniel Welch
CHM | Chairman | 68 | 19/01/2022 |
Sharon Tetlow
BRD | Director/Board Member | 66 | 29/03/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/9/26 | Conversion | Chief Technology Officer | -20,040 | 0.0143% | ||
| 1/9/26 | Exercice | Chief Technology Officer | 65,329 | 0.0467% | ||
| 18/8/26 | Exercice | Chief Technology Officer | 43,329 | 0.0310% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.54% | -0.32% | -26.07% | -68.63% | 1.53B | |
| +0.34% | -3.03% | +37.45% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +83.90% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +105.71% | 53.03B | |
| -1.54% | -0.79% | +26.76% | +55.86% | 45.99B | |
| -0.78% | -2.81% | +18.00% | +99.08% | 42.45B | |
| +0.36% | +0.96% | +226.61% | +932.70% | 40.45B | |
| -0.26% | -4.20% | +10.86% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +90.26% | 34.47B | |
| -2.72% | -8.79% | +22.58% | -5.63% | 24.23B | |
| Average | -0.27% | +3.20% | +44.55% | +139.95% | 39.41B | |
| Weighted average by Cap. | -0.20% | +3.11% | +49.19% | +159.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.67M 37.38M 34.56M 31.3M 58.48M 3.97B 59.19M 413M 165M 2.08B 156M 153M 6.59B | 45.45K 40.78K 37.7K 34.14K 63.79K 4.33M 64.56K 451K 180K 2.27M 171K 167K 7.19M |
| Net income | -314M -282M -260M -236M -440M -29.89B -446M -3.11B -1.24B -15.64B -1.18B -1.15B -49.65B | -471M -423M -391M -354M -661M -44.86B -669M -4.67B -1.86B -23.47B -1.77B -1.73B -74.52B |
| Net Debt | -967M -868M -802M -727M -1.36B -92.11B -1.37B -9.59B -3.82B -48.2B -3.63B -3.55B -153B | -559M -502M -464M -420M -785M -53.26B -794M -5.55B -2.21B -27.87B -2.1B -2.05B -88.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$21.85 | +1.72% | 248,026 |
| 28/10/26 | US$21.48 | -0.32% | 987,484 |
| 27/10/26 | US$21.55 | +2.13% | 731,613 |
| 26/10/26 | US$21.10 | -0.42% | 688,970 |
| 23/10/26 | US$21.19 | -3.37% | 798,110 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GPCR Stock
Select your edition
All financial news and data tailored to specific country editions
